Drugs / Consensus Interferon-Alpha
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00084279 | Apr 2004 → Apr 2006 | chronic hepatitis C virus infection | InterMune | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Consensus Interferon-Alpha | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00084279 ↗ |
| Known as | CIFN | “Consensus Interferon-Alpha (CIFN) Plus Interferon Gamma-1b (IFN-γ 1b) With or Without Ribavirin (RBV)” NCT00084279 ↗ |
| Route | Subcutaneous | “interferon alfacon: 0.3 mL and 0.5 mL, SQ, once a day” NCT00084279 ↗ |